Valuation : Aoxing Pharmaceutical Company, Inc.

Market Cap 23.62M 20.27M 18.99M 17.37M 32.72M 2.26B 32.84M 225M 87.86M 1.14B 88.7M 86.76M 3.76B P/E 2015
20.1x
P/E 2016 23.2x
Enterprise Value 42.18M 36.2M 33.91M 31.02M 58.43M 4.03B 58.64M 401M 157M 2.03B 158M 155M 6.72B EV / Sales 2015
5.77x
EV / Sales 2016 2.11x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
17-08-04 Aoxing Pharmaceutical Company, Inc. Executive Changes CI
17-05-15 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
17-02-13 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016 CI
16-11-13 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016 CI
16-10-04 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016 CI
16-05-16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016 CI
16-02-08 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016 CI
16-02-01 Aoxing Pharmaceutical Company, Inc. Announces Executive Changes CI
15-12-10 Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai CI
15-12-04 Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center CI
15-12-01 Aoxing Pharmaceutical Company, Inc. Announces Management Changes CI
15-11-13 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015 CI
15-10-12 Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt CI
1 day+90.91%
Current month-40.00%
1 month-40.00%
3 months-50.00%
6 months-40.00%
Current year-36.36%
1 week 0
Extreme 0.0011
0
1 month 0
Extreme 0.0011
0
Current year 0
Extreme 0.0011
0.01
1 year 0
Extreme 0.0011
0.01
3 years 0
Extreme 0.0011
0.02
5 years 0
Extreme 1.0E-6
0.02
10 years 0
Extreme 0
0.66
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Change 5-day change 1-year change 3-year change Capi.($)
+90.91%0.00%-80.19%+90.91% 801K
+2.50%-1.91%-34.71%-51.54% 1.91B
-0.79%-3.43% - - 1.74B
-2.26%-11.03%-18.51%+174.02% 1.22B
+0.88%-7.94%-52.89%+13.64% 1.12B
-0.65%+1.05%+202.73%+939.17% 1.12B
+2.28%+0.42%+53.65%+41.95% 990M
-3.10%-13.69%+0.43%+68.28% 823M
-0.94%-3.54%+28.33%+192.96% 812M
+1.90%-22.53%+45.85%-16.56% 593M
Average +9.07%-5.12%+16.08%+161.42% 1.03B
Weighted average by Cap. +0.10%-4.14%+21.33%+166.34%

Financials

2015 2016
Net sales 25.48M 21.86M 20.48M 18.74M 35.29M 2.43B 35.42M 242M 94.77M 1.23B 95.67M 93.58M 4.06B 32.33M 27.74M 25.99M 23.78M 44.78M 3.09B 44.94M 308M 120M 1.56B 121M 119M 5.15B
Net income 5.49M 4.71M 4.42M 4.04M 7.61M 525M 7.64M 52.28M 20.44M 265M 20.63M 20.18M 876M 2.06M 1.77M 1.66M 1.52M 2.85M 197M 2.87M 19.61M 7.67M 99.26M 7.74M 7.57M 328M
Net Debt 24.8M 21.28M 19.94M 18.24M 34.36M 2.37B 34.48M 236M 92.25M 1.19B 93.13M 91.1M 3.95B 18.56M 15.93M 14.92M 13.65M 25.71M 1.77B 25.8M 177M 69.03M 894M 69.68M 68.16M 2.96B
Logo Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc., through its subsidiary, InfoEd Tech Limited, provides educational technology solutions aimed at overcoming language barriers in the Asia Pacific region. By converting training programs into video formats and utilizing artificial intelligence (AI) for multilingual support, it offers accredited training programs that cater to the needs of professionals across various industries.
Employees
-
Date Price Change Volume
26-08-24 US$0.002100 +90.91% 475
26-08-21 US$0.001100 -47.62% 10,000
  1. Stock Market
  2. Stocks
  3. AOXG Stock